India's Biocon to divest in Germany's AxiCorp
India's Bangalore-based Biocon has decided that it will be divesting its stake in the German drug distributor, AxiCorp GmbH. Some three years back it had taken up controlling stake in the company and now it will be selling the shares to the minority shareholders of the company.
AxiCorp as a company deals with marketing and distribution of various products related to the healthcare industry. It was started by a group of industry professionals in 2002, who wanted to milk the distribution market in Germany and Europe.
Meanwhile, talking about the divestment, Kiran Mazumdar-Shaw, MD Biocon said that that since they did the Pfizer deal, the relevance of AxiCorp has changed and that is why it was best possible to move out of the industry.
In 2008, Biocon had taken over 78 per cent stake in AxiCorp by paying $43.7 million. It is now going to sell its shares for about $59.37 million.
As for the Pfizer deal, it happened in October last year when Biocon sold off its global rights to commercialise bio-similar diabetes treatment to it. This was done so that selling the drugs in less-regulated emerging markets was possible.
European Commission President Jean-Claude Juncker’s proposal to expand Eurozone by bringing more countries into it has triggered controversy, mainly in Germany, where Chancellor Angela Merkel is seeking re-election.
Wall Street soared to record highs on Friday, thanks to robust trading in telecommunication shares as well as bouncing back of technology shares after a couple of days of declines.
The European Union’s effort to increase tax on turnover of technology multinationals like Google and Amazon gained momentum as nearly one third of EU states are now in support of the plan, French Finance Minister Bruno Le Maire said on Friday.
Stock price of electric vehicle maker Tesla gained more than 3 per cent on Thursday, after the company’s founder and CEO Elon Musk confirmed plans to introduce an electric semi-truck.
Bitcoin suffered its steepest decline since January 2015 on Friday after a senior executive of China’s state-backed internet finance body said the controversial digital currency could pose risks because Bitcoins and other cryptocurrencies could be
Cupertino, California-based Apple Incorporated has quietly increased prices for the 256GB and 512GB models of its iPad Pro by $50, MacRumors reported.